Sera Prognostics appoints Sandra A.J. Lawrence to Board of Directors

SERA PROGNOSTICS, INC.

Appointed effective Nov 29, 2021 as Class II director with term expiring at 2023 annual meeting.
Received non-qualified stock option with $240,000 grant date fair value, vesting in 36 monthly installments.
Entitled to annual cash retainer of $35,000, prorated for 2021 service.
Lawrence brings extensive board experience including Evergy, American Shared Hospital Services, and Recology.
Former EVP/CFO of Children's Mercy Hospital; holds MBA from Harvard Business School.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sandra A.J. Lawrence

Director

SERA · SERA PROGNOSTICS, INC.

Effective: 2021-11-29
Filed: November 30, 2021, 6:59 PM ET

On November 29, 2021, the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”) appointed Sandra A.J. Lawrence, effective November 29, 2021 (the “Effective Date”), as a director to the Board to serve as a Class II Director with a term expiring at the Company’s 2023 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandra A.J. Lawrence was appointed as Director at SERA PROGNOSTICS, INC..

Action: appointed
Role: Director

Exact text from the filing

On November 29, 2021, the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”) appointed Sandra A.J. Lawrence, effective November 29, 2021 (the “Effective Date”), as a director to the Board to serve as a Class II Director with a term expiring at the Company’s 2023 annual meeting of stockholders.

View on SEC.gov

SERA PROGNOSTICS, INC. filing history →

Source: SEC EDGAR

accession 0001534969-21-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.